Famotidine
Brand names: Pepcid
Class: 🔥 PPIs & H2 Blockers
What examiners watch for is recognition that famotidine is the H2 blocker that replaced ranitidine after the NDMA contamination recall. It reversibly blocks the histamine-2 receptor on parietal cells, reducing acid output. Indications are mild GERD, peptic ulcer disease (less effective than a PPI), allergic reactions as adjunct H2 component (with an H1 antihistamine), and stress-ulcer prophylaxis. Onset is faster than a PPI but the effect is weaker and tachyphylaxis develops over weeks. Adjust dose for renal impairment — accumulation can cause confusion in older adults. On the exam, famotidine is the de-escalation agent for patients on long-term PPIs who develop hypomagnesemia, fractures, or recurrent C. diff.
✅ Indications
GERD, PUD (mild), allergic reactions (H2 component), stress ulcer prevention.
⚙️ Mechanism of Action
H2 receptor antagonist.
📏 Dosing
20–40 mg PO BID (or once daily HS).
🚫 Contraindications
Hypersensitivity.
⚠️ Adverse Effects
Renal accumulation → confusion/delirium (esp elderly), headache.
🔬 Monitoring
Renal function; mental status in elderly.
💎 Board Pearls
- 👵 BEERS CRITERIA at standard doses in patients with CrCl <50 (confusion).
- 📊 Renal dose adjust: CrCl <50 → 20 mg daily.
- 💊 Replaced ranitidine (withdrawn 2020 for NDMA contamination).
Practice Questions
An 84-year-old male on famotidine (Pepcid) 40 mg at bedtime for reflux presents with 3 days of new confusion and mild lethargy. His baseline serum creatinine last month was 1.6 mg/dL with an estimated CrCl of 38 mL/min. Which assessment finding best explains his presentation?
Related Drugs in This Class
- Omeprazole — Prilosec
- Pantoprazole — Protonix
Sources
Ready to practice?
1,500+ AANP-style questions with rationales — free trial.